1. (-)-Epigallocatechin-3-gallate encapsulated realgar nanoparticles exhibit enhanced anticancer therapeutic efficacy against acute promyelocytic leukemia
    Wei Fang et al, 2019, Drug Delivery CrossRef
  2. Comparison of gene regulatory networks to identify pathogenic genes for lymphoma
    Xiao Yu et al, 2020, Journal of Bioinformatics and Computational Biology CrossRef
  3. (–)-Epigallocatechin-3-gallate induces apoptosis and differentiation in leukaemia by targeting reactive oxygen species and PIN1
    Fernanda Isabel Della Via et al, 2021, Scientific Reports CrossRef
  4. N6-Methyladenosine-Related lncRNAs Are Novel Prognostic Markers and Predict the Immune Landscape in Acute Myeloid Leukemia
    Lulu Zhang et al, 2022, Frontiers in Genetics CrossRef
  5. Epigallocatechin 3-gallate: From green tea to cancer therapeutics
    Manzar Alam et al, 2022, Food Chemistry CrossRef
  6. Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer
    Saleh A. Almatroodi et al, 2020, Molecules CrossRef
  7. NLS-RARα contributes to differentiation block and increased leukemogenic potential in vivo
    Ling Xiong et al, 2020, Cellular Signalling CrossRef
  8. Potentiating Gilteritinib Efficacy Using Nanocomplexation with a Hyaluronic Acid–Epigallocatechin Gallate Conjugate
    Ki Hyun Bae et al, 2024, Polymers CrossRef
  9. Epigallocatechin-3-gallate effects on leukemia cells
    Maliheh Moradzadeh, 2025, Tea in Health and Disease Prevention CrossRef
  10. Epigallocatechin-3-gallate promotes apoptosis and reversal of multidrug resistance in esophageal cancer cells
    Liang Liu et al, 2017, Pathology - Research and Practice CrossRef
  11. Cancer Stem Cells as Therapeutic Targets for Gastrointestinal Cancers
    Jyothi Priya Mandala et al, 2020, Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers CrossRef
  12. The Effects of Green Tea Catechins in Hematological Malignancies
    Fernanda Isabel Della Via et al, 2023, Pharmaceuticals CrossRef